+++J. Med. Chem

[Татка]

ПОМОГИТЕ, ПОЖАЛУЙСТА
1)New Arylpiperazine 5-HT1A Receptor Ligands Containing the Pyrimido[2,1-f]purine Fragment: Synthesis, in Vitro, and in Vivo Pharmacological Evaluation
Sławomir Jurczyk, Marcin Kołaczkowski, Ewa Maryniak,Paweł Zajdel, Maciej Pawłowski, Ewa Tatarczyńska, Aleksandra Kłodzińska, Ewa Chojnacka-Wójcik, Andrzej J. Bojarski, Sijka Charakchieva-Minol, Beata Duszyńska, Gabriel Nowak, and Dorota Macig
J. Med. Chem., 2004, 47 (10), pp 2659–2666
DOI:

DOI:

http://dx.doi.org/10.1021/jm030946u

2)Structure−Affinity Relationship Study on N-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-Aryl-1-Piperazinealkylamides, a New Class of 5-Hydroxytryptamine7 Receptor Agents
Marcello Leopoldo, Francesco Berardi, Nicola A. Colabufo, Marialessandra Contino, Enza Lacivita, Mauro Niso, Roberto Perrone, and Vincenzo Tortorella
J. Med. Chem., 2004, 47 (26), pp 6616–6624
DOI:

DOI:

http://dx.doi.org/10.1021/jm049702f

3)Structure−Activity Relationship Study on N-(1,2,3,4-Tetrahydronaphthalen-1-yl)-4-aryl-1-piperazinehexanamides, a Class of 5-HT7 Receptor Agents. 2
Marcello Leopoldo,Enza Lacivita, Marialessandra Contino, Nicola A. Colabufo, Francesco Berardi, and Roberto Perrone
J. Med. Chem., 2007, 50 (17), pp 4214–4221
DOI:

DOI:

http://dx.doi.org/10.1021/jm070487n

[eFo]

[Татка]

СПАСИБО)